Drug General Information (ID: DDIHQ284JU)
  Drug Name Fentanyl Drug Info Guanfacine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Narcotic Analgesics Antiadrenergic Agents
  Structure

 Mechanism of Fentanyl-Guanfacine Interaction (Severity Level: Moderate)
     Increased risk of bradycardia Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Fentanyl Guanfacine
      Mechanism Bradycardia Bradycardia
      Key Mechanism Factor 1
Factor Name Bradycardia
Factor Description Bradycardia is a slow heart rate in which the heart beats less than 60 times per minute. If the heart rate is very slow and the heart is not pumping enough oxygen-rich blood to the body, and you may feel dizzy, very tired or weak, and short of breath.
      Mechanism Description
  • Increased risk of bradycardia by the combination of Fentanyl and Guanfacine 

Recommended Action
      Management While some centrally acting alpha-antagonists, like guanfacine, are used preoperatively, it is recommended that the clinician monitor for bradycardia and be prepared for its consequences.

References
1 Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
2 Kharasch ED, Whittington D, Hoffer C "Influence of Hepatic and Intestinal Cytochrome P4503A Activity on the Acute Disposition and Effects of Oral Transmucosal Fentanyl Citrate." Anesthesiology 101 (2004): 729-737
3 Burney RG "Bradycardia during epidural anesthesia in a patient receiving guanfacine." Anesthesiology 77 (1992): 1228-9